ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Thursday, 12 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Earnings Call

NCC Earnings Call: Key Takeaways

Management is evasive, refusing all FY27 guidance despite a record ₹83,400 crore order book. Financials are deteriorating with standalone revenue down 9% YoY and margins contracting to 8.44%.

Highlights
Revenue growthStandalone revenue declined 9% YoY for the full year FY26.
MarginsEBITDA margins contracted to 8.44% from 9.21% YoY.
Order bookRecord high at ₹83,400 crore, representing a 4x book-to-bill ratio.
Demand visibilityStrong order book visibility but execution hindered by macroeconomic uncertainties.
Management confidenceExtremely cautious and defensive; refused to provide any forward guidance.

Growth

Growth is negative; standalone turnover declined 9% in FY26 due to Jal Jeevan Mission execution delays.

Outlook

FY27 Capex planned at ₹500 crore. No revenue or margin guidance provided due to global uncertainty.

Risks

Severe uncertainty in payment cycles and inflationary pressures; management refused to provide any forward-looking numbers.

Source

Earnings Call filed with NSE, NSE: NCC. Summary written with AI assistance from the document.

Read the document ↗

NCC Ltd: key numbers

Share price
₹137.28
Market cap
₹8,619 Cr
Revenue (annual)
₹20,823 Cr
Net profit (annual)
₹675.3 Cr
P/E (TTM)
11.8×Sector 33.5×
Promoter holding
23.19%+0.11% QoQ
FII holding
10.44%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from NCC Ltd

All →
19:38 IST BSE
Management Change

NCC Management Change

NCC Limited re-appointed three executive directors, A V Ranga Raju Alluri as MD and two Whole-time Directors, effective 1 April 2027 for 60 months. Only a board-level leadership renewal is disclosed, with no financial amount.

Execution
Re-appointment term of 60 months from 2027-04-01